Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.

Regan Anderson TM, Ma S, Perez Kerkvliet C, Peng Y, Helle TM, Krutilina RI, Raj GV, Cidlowski JA, Ostrander JH, Schwertfeger KL, Seagroves TN, Lange CA.

Mol Cancer Res. 2018 Jul 10. doi: 10.1158/1541-7786.MCR-18-0410. [Epub ahead of print]

PMID:
29991529
2.

Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.

Leehy KA, Regan Anderson TM, Daniel AR, Lange CA, Ostrander JH.

J Mol Endocrinol. 2016 Apr;56(3):R99-R114. doi: 10.1530/JME-15-0322. Epub 2016 Feb 1. Review.

PMID:
26831511
3.

Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.

Regan Anderson TM, Ma SH, Raj GV, Cidlowski JA, Helle TM, Knutson TP, Krutilina RI, Seagroves TN, Lange CA.

Cancer Res. 2016 Mar 15;76(6):1653-63. doi: 10.1158/0008-5472.CAN-15-2510. Epub 2016 Jan 29.

4.

Cytoplasmic PELP1 and ERRgamma protect human mammary epithelial cells from Tam-induced cell death.

Girard BJ, Regan Anderson TM, Welch SL, Nicely J, Seewaldt VL, Ostrander JH.

PLoS One. 2015 Mar 19;10(3):e0121206. doi: 10.1371/journal.pone.0121206. eCollection 2015.

5.

Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.

Regan Anderson TM, Peacock DL, Daniel AR, Hubbard GK, Lofgren KA, Girard BJ, Schörg A, Hoogewijs D, Wenger RH, Seagroves TN, Lange CA.

Cancer Res. 2013 Sep 15;73(18):5810-20. doi: 10.1158/0008-5472.CAN-13-0523. Epub 2013 Aug 8. Erratum in: Cancer Res. 2013 Nov 1;73(21):6538.

Supplemental Content

Loading ...
Support Center